Explore HKAPI’s key moments: Policy forums, workshops, and stakeholder events driving healthcare access in Hong Kong and Macao.
2026
Ms Linda Chan, Lead of the Regulatory Affairs Working Group, delivered an opening speech to kick start the event, and shared the industry’s proposal for data exclusivity in latter session.
醫藥法規工作小組成員
Participants had a fruitful discussion regarding the draft DH guidelines.
香港科研製藥聯會高級執行董事陳素娟女士致開幕辭。
Around 100 participants from the industry attended the event.
Our sincere thanks to guest speakers and partners for making this forum possible.
Mr Pan Jianhong from the Center for Drug Evaluation, National Medical Products Administration (NMPA), shared his perspectives on “Politics and Guidelines related to Real-World Research in the Chinese Mainland.”